| 1.64 -0.01 (-0.61%) | 11-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.15 | 1-year : | 2.42 |
| Resists | First : | 1.84 | Second : | 2.07 |
| Pivot price | 1.61 |
|||
| Supports | First : | 1.47 | Second : | 1.22 |
| MAs | MA(5) : | 1.56  |
MA(20) : | 1.67 |
| MA(100) : | 1.61 |
MA(250) : | 1.44 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 40.2 |
D(3) : | 23.2 |
| RSI | RSI(14): 46.8 |
|||
| 52-week | High : | 2.07 | Low : | 0.85 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ OGI ] has closed below upper band by 43.2%. Bollinger Bands are 4.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.7 - 1.71 | 1.71 - 1.71 |
| Low: | 1.6 - 1.61 | 1.61 - 1.62 |
| Close: | 1.62 - 1.64 | 1.64 - 1.65 |
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Tue, 21 Oct 2025
Organigram Global Announces Update to CEO Succession Plan - Business Wire
Thu, 02 Oct 2025
Organigram (TSX:OGI): Fresh Index Inclusion Sparks New Look at Valuation - Yahoo Finance
Tue, 30 Sep 2025
Is Organigram Global Inc. (TSE:OGI) Trading At A 50% Discount? - Yahoo Finance
Sat, 20 Sep 2025
Organigram Is No Longer A Bargain (Rating Downgrade) - Seeking Alpha
Tue, 02 Sep 2025
Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada’s GDP in 2024 - Business Wire
Mon, 18 Aug 2025
Organigram: The Capital Efficient Market Leader Trading At A Discount (NASDAQ:OGI) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 134 (M) |
| Shares Float | 94 (M) |
| Held by Insiders | 32.3 (%) |
| Held by Institutions | 6 (%) |
| Shares Short | 5,200 (K) |
| Shares Short P.Month | 5,280 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.88 |
| Profit Margin | 3.4 % |
| Operating Margin | -3 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 72.4 % |
| Gross Profit (p.s.) | 0.56 |
| Sales Per Share | 1.67 |
| EBITDA (p.s.) | -0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 3 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 164 |
| PEG Ratio | 0 |
| Price to Book value | 0.56 |
| Price to Sales | 0.98 |
| Price to Cash Flow | 79.92 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|